D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is ...

"There is a clear unmet need for therapies," researcher says ...

The scientists at the Wellcome Genome Campus are aiming to make healthcare breakthroughs — but first they must grapple with ...

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

Good morning, and welcome to Sarepta's preliminary data readout of its Phase I/II studies for DM1 and FSHD. As a reminder, today's program is being recorded. At this time, I'll turn the call over to ...

Duality Biotherapeutics, Inc. (Hong Kong Stock Exchange Code: 09606.HK, hereinafter referred to as "DualityBio" ...

At this time, I would like to welcome everyone to the Karyopharm Therapeutics' call to discuss top line results from the Phase III SENTRY trial. There will be a question-and-answer session to follow.

Nominated KRRO-121 development candidate for the potential treatment of hyperammonemia in patients with urea cycle disorders and hepatic encephalopathyAdvanced GalNAc-conjugated oligonucleotide for ...

Detailed price information for Onkure Therapeutics Inc (OKUR-Q) from The Globe and Mail including charting and trades.

Forget Survival Of The Fittest. Humans Conquered Our Planet By Sharing Ideas. In A Nutshell Humans spread across nearly every ...

A new paper in Genome Biology and Evolution, indicates that while the COVID-19 virus has developed rapidly since 2019, it has done so within limited genetic channels. These genetic limits have ...